5 Results for "

ani

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "ani" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-119981
CAS No.: 356102-14-2
Purity:  99.12%
Target:  

Chloride Channel

Research Areas:  

Neurological Disease Cancer

Ani9 is an ANO1 inhibitor, with an IC50 of 77 nM. Ani9 can inhibit smooth muscle contractions in mice and is applicable in research related to diseases such as tumors .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-112257
CAS No.: 1010396-29-8
Purity:  99.93%
Target:  

Androgen Receptor

Research Areas:  

Metabolic Disease

S-23 is an orally active selective androgen receptor modulator (SARM) with a Ki of 1.7 nM. S-23 induces androgen receptor (AR)-mediated transcriptional activation in CV-1 cells. S-23 increases prostate, seminal vesicle, and levator ani muscle weights in castrated rats .
loading...
    loading...
Cat. No.: HY-117102
CAS No.: 931417-26-4
Purity:  98.13%
Research Areas:  

Cancer

ANI-7 is an activator of aryl hydrocarbon receptor (AhR) pathway. ANI-7 inhibits the growth of multiple cancer cells, and potently and selectively inhibits the growth of MCF-7 breast cancer cells with a GI50 of 0.56 μM. ANI-7 induces CYP1-metabolizing mono-oxygenases by activating AhR pathway, and also induces DNA damage, checkpoint Kinase 2 (Chk2) activation, S-phase cell cycle arrest, and cell death in sensitive breast cancer cell lines .
loading...
    loading...
Cat. No.: HY-105318
CAS No.: 328947-93-9
Purity:  98.58%
Target:  

Androgen Receptor

Research Areas:  

Metabolic Disease Endocrinology

LGD-2226 is a selective and orally active androgen receptor modulator with an EC50 of 0.2 nM and a Ki of 1.5 nM for human androgen receptor. LGD-2226 shows tissue selectivity in animal models, with reduced effects on prostate compared to muscle. LGD-2226 can be used for muscle wasting, osteoporosis and sexual dysfunction .
loading...
    loading...
Cat. No.: HY-105318R
CAS No.: 328947-93-9
LGD-2226 (Standard) is the analytical standard of LGD-2226 (HY-105318). This product is intended for research and analytical applications. LGD-2226 is a selective and orally active androgen receptor modulator with an EC50 of 0.2 nM and a Ki of 1.5 nM for human androgen receptor. LGD-2226 shows tissue selectivity in animal models, with reduced effects on prostate compared to muscle. LGD-2226 can be used for muscle wasting, osteoporosis and sexual dysfunction .
loading...
    loading...